SCHEMBL20021151

SCHEMBL20021151

Cc1cc2c(ccc(=O)n2Cc2ccccc2)c(-c2ccc(Cl)cc2)c1CC=O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
KDM4E B2RXH2 2/20 0.42
PTGDR2 Q9Y5Y4 2/20 0.41
PDE1C Q14123 2/20 0.39
LMNA P02545 1/20 0.39
GAA P10253 1/20 0.39
HPGD P15428 1/20 0.39
HTT P42858 1/20 0.39
PDE9A O76083 1/20 0.39
PTGES2 Q9H7Z7 3/20 0.38
PTGES O14684 1/20 0.38
AR P10275 1/20 0.37
ATM Q13315 1/20 0.37
ALDH1A1 P00352 1/20 0.37
MAPK8 P45983 1/20 0.37
MAPK9 P45984 1/20 0.37
MDM2 Q00987 2/20 0.36
KCNH2 Q12809 1/20 0.36
CYP19A1 P11511 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20021094 0.88 MEN1 (0.46) MEN1KMT2AKDM4EPTGDR2PDE1C
SCHEMBL20021131 0.85 PTGDR2 (0.47) MEN1KMT2AKDM4EPTGDR2LMNA
SCHEMBL3297264 0.73 CYP3A4 (0.42) MEN1KMT2APTGDR2PTGES2PTGES
SCHEMBL252857 0.73 PTGES2 (0.39) MEN1KMT2AKDM4EPTGDR2PDE1C
SCHEMBL252858 0.73 PTGES2 (0.39) MEN1KMT2AKDM4EPTGDR2PDE1C
SCHEMBL3312482 0.73 PTGDR2 (0.40) MEN1KMT2AKDM4EPTGDR2PTGES2
SCHEMBL15182599 0.73 PTGES2 (0.41) MEN1KMT2AKDM4EPTGDR2PTGES2
SCHEMBL10284225 0.68 KDM4E (0.44) MEN1KMT2AKDM4EPTGDR2LMNA
SCHEMBL20021077 0.67 CNR2 (0.44) KMT2AKDM4EPTGDR2GAAHPGD
SCHEMBL30783430 0.66 KMT2A (0.70) MEN1KMT2AKDM4ELMNAGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2588455-B1 2-QUINOLINYL-ACETIC ACID DERIVATIVES AS HIV ANTIVIRAL COMPOUNDS GILEAD SCIENCES INC (US) 2018-04-04 EP disclosed